: Recently saw a +7.43% jump in trading, signaling potential renewed interest despite past volatility.
: Specializes in photonics technology for AI hardware. Recent financial results have highlighted its role in global tech advancements, making it a frequent pick for 2026 growth.
: A clinical-stage biotech focused on severe asthma. Analysts from TipRanks maintain a Strong Buy consensus, noting its lead candidate UPB-101 has shown promising early inflammation-reduction data. junk stocks to buy
: Developing gene therapies for rare neurological disorders like Rett syndrome. It carries a unanimous Strong Buy from analysts, with significant upside potential tied to upcoming clinical updates.
Some larger "junk" names are companies that have seen massive price crashes but are showing signs of life as of late April 2026: : Recently saw a +7
: A Bitcoin mining company gaining attention due to operational expansion and energy efficiency. It is often cited as a top pick for investors seeking high-volatility cryptocurrency exposure.
The following table summarizes the monthly performance of some top-performing high-risk stocks as of April 14, 2026: Monthly Performance CHGG PDSB PDS Biotechnology HURA TuHURA Biosciences CURV Torrid Holdings Data sourced from NerdWallet . Risks to Consider : A clinical-stage biotech focused on severe asthma
: Identified by Yahoo Finance as a leading penny stock for 2026, driven by high demand for AI-driven conversational commerce. Beaten-Down Stocks with Turnaround Potential